Acetazolamide Sodium Powder via Aseptic Spray Drying

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The high cost and energy inefficiency of lyophilization processes for producing acetazolamide sodium powder for injection, coupled with the limited application of spray drying in pharmaceuticals due to solubility issues and potential residual organic solvents, hinder the development of efficient and safe manufacturing methods for acetazolamide sodium.

Innovation Solution

A spray drying method is developed to prepare acetazolamide sodium powder by dispersing acetazolamide powder in water, mixing with a sodium hydroxide solution, filtering, and then aseptically spray drying the solution to produce a powder that can be reconstituted for intravenous administration, utilizing a cyclone system and controlled temperature and gas flow to achieve a stable and amorphous powder form.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If lyophilization is used to prepare acetazolamide sodium powder, then the powder quality and solubility are ensured, but the production cost and energy consumption increase significantly

Engineering Contradiction:
Improvepowder qualityVSAvoidenergy consumption
Core Design Contradiction:
ReliabilityVSUse of energy by stationary object

Solution Approach 1:

The invention changes the processing parameters by using spray drying instead of lyophilization, adjusting the solution concentration (5-20% w/v) and drying conditions to achieve the desired powder quality with lower energy consumption. The spray drying process parameters including inlet temperature, airflow rate, and solution feed rate are optimized to produce amorphous or partially amorphous powder with high solubility.

Inventive Principle:
Principle #35Parameter changes

2Use of energy by stationary object

If spray drying is used to prepare acetazolamide sodium powder, then the energy efficiency and production cost are improved, but the application in pharmaceuticals is limited due to solubility issues and residual solvents

Engineering Contradiction:
Improveenergy efficiencyVSAvoidsolubility
Core Design Contradiction:
Use of energy by stationary objectVSReliability

Solution Approach 1:

The invention optimizes spray drying parameters including solution concentration (5-20% w/v), inlet temperature (150-250°C), and airflow rate to produce powder with amorphous or partially amorphous structure, which enhances solubility. The process is carefully controlled to eliminate residual solvents while maintaining high solubility of acetazolamide sodium.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention uses composite spray drying technology combining acetazolamide sodium solution with specific excipients or carriers to create a composite powder structure that maintains high solubility while enabling efficient spray drying processing. The composite approach addresses both solubility requirements and processing efficiency.

Inventive Principle:
Principle #40Composite materials

3Productivity

If spray drying is used to prepare acetazolamide sodium powder, then the production efficiency and automation are improved, but the process complexity and control requirements increase

Engineering Contradiction:
Improveproduction efficiencyVSAvoidprocess complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The invention employs a spray drying system that integrates multiple functions including solution atomization, heating, drying, and powder collection in a single continuous process. The apparatus combines spray nozzle, drying chamber with temperature control, and cyclone separator to achieve continuous production with automated control, reducing overall process complexity despite high productivity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method significantly reduces production costs and energy consumption compared to lyophilization, while ensuring high bioavailability and safety by eliminating residual organic solvents and maintaining the required pH and crystal structure of acetazolamide sodium, making it suitable for intravenous use.

Implementation Method 1

the liquid droplets contact the heated gas, e.g., air or nitrogen (N2), and then the liquid droplets evaporate to accompany with the nucleation of particles in a short period

Methodology Applied
Scientific EffectEvaporation: Evaporation

Implementation Method 2

the dried particles are collected by a cyclone system incorporated with a bag filter or wet scrubber

Methodology Applied
Scientific EffectCyclone separation: Cyclone Separation

Data Source

PatentUS9511341B2Method for preparing acetazolamide sodium powder
Publication Date: 2016.12.06 SUNNY PHARMTECH
  • US9511341B2 patent drawing
  • US9511341B2 patent drawing
  • US9511341B2 patent drawing

AI summary

A method for preparing acetazolamide sodium powder for injection is provided. The method includes steps of providing an acetazolamide sodium solution; and aseptically spray drying the acetazolamide sodium solution to obtain the acetazolamide sodium powder.